Chemed Corporation (CHE) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chemed Corporation  (NYSE: CHE)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Chemed's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Chemed's ROI in the third quarter of 2026?
Chemed Corporation achieved a return on average invested assets (ROI) of 22.09 % in its third quarter of 2026, this is above CHE's average return on investment of 18.88%.
Chemed Corporation invested over the 12 months ending in its third quarter of 2026 $1,278 million

ROI has improved compared to 21.75% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 52 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 360, from total ROI ranking in the second quarter of 2026 at 369.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -8.77 % -12.47 % -9.41 % -5.75 % -3.03 %
Y / Y Net Income Change TTM 1.29 % -5.29 % 9.22 % 59.69 % 267.93 %
Investment (TTM) in Millions 1,388 1,260 1,214 1,251 1,332
Return On Investment (TTM) 22.09 % 21.75 % 19.79 % 19.39 % 19.9 %
CHE's Overall Ranking # 360 # 369 # 261 # 316 #
Seq. Investment Change TTM 1.11 % -3.7 % -4.05 % -2.35 % -3 %
Seq. Net Income Change TTM 2.69 % 5.85 % -2.06 % -4.87 % -3.97 %
Net Income (TTM) in Millions 282 275 260 265 279

CHE Company Profile >> Back to CHE Roi Comparisons >> See Annual CHE Return On Investment



Return On Investment CHE's Ranking
Within: No.
Industry # 2
Sector # 53
Overall # 360

Return On Investment Statistics
High Average Low
28.52 %
18.88 %
9.81 %
(Dec 31 2020)   (Jun 30 2017)







Financial Statements
Chemed's III. Quarter Investments $ 1,388 Millions CHE's Balance sheet
Chemed's III. Quarter Income $ 72 Millions Quarterly CHE's Income Statement
CHE's Income by Division See CHE's Income by Division


CHE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,251 1,383 1,356 1,145 1,040
Y / Y Investment Growth -9.53 % 1.98 % 18.45 % 10.04 % -8.41 %
Net Income in Millions 265 302 273 250 269
Y / Y Net Income Growth -12.17 % 10.82 % 9.17 % -7.05 % -15.94 %
Annual Return On Investment 21.2 % 21.84 % 20.1 % 21.8 % 25.81 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 21.2 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CHE's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CHE's Competitors
Subscribers only: Roi for Chemed's Suppliers
Subscribers only: Return On Investment for CHE's Customers

Other Ratios
CHE's Roa CHE's Inventory Turnover Ratio CHE's Growth Rates CHE's Dividend Statistics
CHE's Profitability Ratios CHE's Asset Turnover Ratio CHE's Dividend Growth
CHE's Roe CHE's Valuation Ratios CHE's Financial Strength Ratios CHE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %

Date modified: 2026-10-30T13:05:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.